TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Hua Medicine ( (HK:2552) ) is now available.
Hua Medicine has announced a change in the composition of its Remuneration Committee, appointing Mr. Yiu Leung Andy Cheung as a new member effective November 27, 2025. This appointment reflects the company’s ongoing efforts to strengthen its governance structure, potentially impacting its operational efficiency and stakeholder confidence.
The most recent analyst rating on (HK:2552) stock is a Hold with a HK$3.00 price target. To see the full list of analyst forecasts on Hua Medicine stock, see the HK:2552 Stock Forecast page.
More about Hua Medicine
Hua Medicine is a company incorporated in the Cayman Islands, focusing on the pharmaceutical industry. It operates as a group with subsidiaries and is listed on the Hong Kong Stock Exchange under the stock code 2552.
Average Trading Volume: 6,785,616
Technical Sentiment Signal: Buy
Current Market Cap: HK$3.15B
For a thorough assessment of 2552 stock, go to TipRanks’ Stock Analysis page.